Merck Takes Cost-Cutting Therapy, But What Will The Side Effects Be?

Merck is expected to follow its manufacturing cost-cutting program with future initiatives that will impact sales, marketing and R&D and have a more significant impact on new product innovation and top-line growth

More from Archive

More from Pink Sheet